Vanna Chiarion Sileni

Deflazacort and Fluoximesterone in Advanced, Pretreated Breast Cancer

E. Ferrazzí, C. Ghiotto, M. Fiorentino, 1992, Tumori.

Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma.

A. Hauschild, D. Schadendorf, K. Flaherty, 2019, Journal of Clinical Oncology.

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study

P. Queirolo, M. Del Vecchio, V. Chiarion Sileni, 2023, Cancers.

Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis?

P. Muzzio, C. Castoro, L. Evangelista, 2012, Journal of Cancer Research and Therapeutics.